Schaeffer's Top Stock Picks for '25

Cree Stock Flirts with New Lows Following Weak Outlook

Options traders were expecting a post-earnings pullback from CREE stock

Aug 23, 2017 at 9:28 AM
facebook X logo linkedin


Analysts are weighing in on video game retailer GameStop Corp. (NYSE:GME), drug stock Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), and LED specialist Cree, Inc. (NASDAQ:CREE). Here's a quick roundup of today's bearish brokerage notes on shares of GME, RARE, and CREE.

Analysts, Options Traders Bearish on GME Stock

Ahead of the company's earnings release tomorrow evening, GameStop saw its price target dropped to $25 from $28 at SunTrust Robinson. This is still above the stock's close last night at $21.64. Year-to-date, GME has given back 14.3%, and the shares have closed lower the day after earnings in seven of the last eight quarters. 

Options traders certainly appear positioned for a pullback. GameStop has a Schaeffer's put/call open interest ratio (SOIR) of 2.39, which ranks in the 92nd annual percentile. This means put open interest more than doubles call open interest among options set to expire within three months. 

Analysts Crush Ultragenyx After Failed Drug Trial

Ultragenyx Pharmaceutical stock is pointed 11.7% lower in pre-market trading, due to news the company's muscle disease treatment failed in a late-stage study. This would put RARE shares in territory not seen since July 2016, after closing yesterday at $58.85. Several analysts have responded bearishly, including SunTrust Robinson, which downgraded Ultragenyx to "hold" from "buy," and slashed its price target to $55 from $105. Coming into today, nine of 15 brokerage firms had "buy" or "strong buy" ratings on the security. 

Put Traders Applaud CREE Sell-off

Cree stock is down 9.3% before the open -- which would put it in annual-low territory --following the company's downbeat current-quarter earnings outlook. Plus, Deutsche Bank cut its price target to $22 from $24, while J.P. Morgan Securities lowered its CREE target to $23 from $26. The shares closed yesterday at $23.03, not far below their year-over-year breakeven point of $23.53. 

A number of options traders will likely be cheering today's sell-off. For instance, CREE has a 10-day put/call volume ratio of 1.69 across the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), which ranks in the 92nd annual percentile. In other words, put buying was unusually popular relative to call buying ahead of earnings. 

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?